# International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis

> **NCT03447704** · PHASE3 · COMPLETED · sponsor: **Biocad** · enrollment: 228 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** BCD-085
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03447704
- **Lead sponsor:** Biocad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-09
- **Primary completion:** 2018-12-24
- **Final completion:** 2022-03-31
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03447704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03447704, "International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03447704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*